Where does Taiho Pharmaceutical Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Taiho Pharmaceutical Co., Ltd. ranks #2,834 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Taiho Pharmaceutical Co., Ltd. hold?

Taiho Pharmaceutical Co., Ltd. holds 136 US utility patents granted between 2015 and 2025, spanning 16 technology areas.

What is Taiho Pharmaceutical Co., Ltd.'s Innovation Score?

Taiho Pharmaceutical Co., Ltd. has an Innovation Score of 43.2 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Taiho Pharmaceutical Co., Ltd.'s patent grant rate increasing or decreasing?

Taiho Pharmaceutical Co., Ltd.'s recent grant velocity is -35% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Taiho Pharmaceutical Co., Ltd.'s patents?

Taiho Pharmaceutical Co., Ltd.'s patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Taiho Pharmaceutical Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Taiho Pharmaceutical Co., Ltd.

Q: What technology areas does Taiho Pharmaceutical Co., Ltd. focus on?

Taiho Pharmaceutical Co., Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 116 patents. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 136 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Taiho ranks #2,834 of 49,997 tracked US assignees by granted-patent volume, with 136 patents across 16 technology areas.

#2,834
of 49,997 US assignees by volume: Top 29%
by Innovation Score (43.2/100): 14.0
avg claims per patent: -35%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2834 · Foreign Corporation #2,834 · 136 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 136 grants
TOP-DECILE #2,834/49,997
PHOTO-FINISH Shell USA
CPC-FOCUS A61P · 16 areas
INNOV-PAR 43.2/100
CLAIMS-RICH 14.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -35% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shell USA, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Hadal · near

43
MacDon Industries · near

43
Meijo University · near

43
Taiho Pharmaceutical · this assignee

43
Volterra Semiconductor · near

43
3D Lighting… · lowest

7

What this shows Taiho's Innovation Score is 43.2/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Taiho's grants concentrate

Taiho Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 16 CPC subclasses with 85.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (20 grants) versus a trough of 6 in 2022. By volume, Taiho sits between Shell USA, Inc. and Freni Brembo S.P.A..

Taiho's three-year grant acceleration

From 2019–2021 to 2022–2024, Taiho Pharmaceutical Co., Ltd. moved from 44 to 24 grants (0.55x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,581. See the growth leaderboard.

Shell USA

136
SK Chemicals

136
Syracuse Universi…

136
Sion Power

136
Taiho Pharmaceuti… ◀

136
Baylor University

135
Chemocentryx

135
Forum US

135
Freni Brembo S P A

135

What this shows Taiho holds 136 patents at rank #2,834, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Taiho

By rank, the assignees closest to #2,834 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Taiho's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Taiho, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (43 here).

MacDon Industries Ltd. 43 Volterra Semiconductor LLC 43 Meijo University 43 Hadal, Inc. 43

Similar claim depth

Nearest assignees by average claims per patent (14.0 here).

I.M.A. Industria Macchine Automatiche S.P.A. 14.0 avg G.D Societa' PER Azioni 14.0 avg Sorenson IP Holdings, LLC 14.0 avg Airoha Technology Corp. 14.0 avg

Taiho's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Taiho Pharmaceutical Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	8.8%
2016	10	7.4%
2017	20	14.7%
2018	17	12.5%
2019	18	13.2%
2020	11	8.1%
2021	15	11.0%
2022	6	4.4%
2023	8	5.9%
2024	10	7.4%
2025partial year	9	6.6%

Which technologies does Taiho Pharmaceutical Co., Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 116

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 103

C07D - Heterocyclic Compounds 71

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 17

C07K - Peptides 16

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C07C - Acyclic OR Carbocyclic Compounds 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

C12Y - Enzymes 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

B01D - Separation 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 15 of 16 technology areas

Where it ranks

Overall rank by patents

#2,834

of 49,997 tracked assignees

Innovation Score

43.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Taiho Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.

Taiho Pharmaceutical Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 85.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #2,834 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Taiho Pharmaceutical Co., Ltd. against Shell USA, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.